Vendanta Biosciences raises $50 mln
Vendanta Biosciences said June 6 that it raised $50 million equity financing from investors including Rock Springs Capital, Invesco Asset Management and Health For Life Capital (Seventure). PureTech also joined in the financing. Cambridge, Massachusetts-based Vendanta is developing therapies designed to modulate the human microbiome.
6 June 2016•1 min read
